miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas.
about
Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).Tumor miR-125b predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection.A MicroRNA Expression Signature In Taxane-anthracycline-Based Neoadjuvant Chemotherapy Response.Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression.Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma.Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines.Dynamics of miRNA transcriptome during gonadal development of zebrafish.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.MicroRNA as potential biomarkers in Glioblastoma.The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas.Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-β1-dependent activation of Smad/ERK signalingThe microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.MicroRNA-141-3p promotes glioma cell growth and temozolomide resistance by directly targeting p53.miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.Noncoding RNAs Regulating NF-κB Signaling.Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model.The Network of Non-coding RNAs in Cancer Drug Resistance
P2860
Q34478948-12C5730F-57D4-43D1-8C25-615272DDF25DQ35713525-CD8485D6-64D6-4BE0-BCF0-EAEDE50638B8Q35739548-B98236CC-C40F-4E84-A60F-A93BE105DF00Q36181081-6824E95D-4ADB-43E0-A687-54DDF53B55C1Q37317631-249FD4CF-62BF-479B-B748-DE3F31F1418FQ37536715-2173D216-E418-4B76-85D0-348A259C077EQ37682209-B36D969E-4B50-4978-B45B-84B837B51008Q38546133-E75EFC6D-A122-45D7-8BBA-6B1AAEA46CB2Q38590626-6A03D8AD-FB72-489D-80AE-57A01ED7AF3BQ38683271-66D92215-F1FF-4E78-B381-69857F91AC9BQ38724559-D468E9EC-CF6F-4092-8200-005C4E119986Q38936321-8B7D45FB-4B98-4506-B98A-B1F2B9BD51F3Q42378507-8872ED23-3A7A-4652-B64B-26477BDAB373Q49888038-9984FA16-E29D-47B0-B631-54F9C6904379Q50000797-31927E17-23DD-4943-8834-FA57D29A4FEFQ51664715-C63D885E-B87D-4346-8C85-3FDC2489CD47Q55342124-BF164D0A-551D-4DD7-BFA8-73D6FE43D512Q58694197-35F13F50-82CF-42F5-AA34-5DF22F732404
P2860
miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
miR-125b controls apoptosis an ...... and NKIRAS2 in glioblastomas.
@ast
miR-125b controls apoptosis an ...... and NKIRAS2 in glioblastomas.
@en
miR-125b controls apoptosis an ...... and NKIRAS2 in glioblastomas.
@nl
type
label
miR-125b controls apoptosis an ...... and NKIRAS2 in glioblastomas.
@ast
miR-125b controls apoptosis an ...... and NKIRAS2 in glioblastomas.
@en
miR-125b controls apoptosis an ...... and NKIRAS2 in glioblastomas.
@nl
prefLabel
miR-125b controls apoptosis an ...... and NKIRAS2 in glioblastomas.
@ast
miR-125b controls apoptosis an ...... and NKIRAS2 in glioblastomas.
@en
miR-125b controls apoptosis an ...... and NKIRAS2 in glioblastomas.
@nl
P2093
P2860
P356
P1476
miR-125b controls apoptosis an ...... and NKIRAS2 in glioblastomas.
@en
P2093
A Kappeler
E Vassella
P2860
P2888
P356
10.1038/CDDIS.2014.245
P577
2014-06-05T00:00:00Z
P5875
P6179
1051502869